S&P 500
(-0.27%) 4 288.05 points
Dow J
(-0.47%) 33 508 points
Nasdaq
(0.14%) 13 219 points
Oil
(0.39%) $91.14
Gas
(-1.09%) $2.90
Gold
(-0.34%) $1 859.70
Silver
(-1.78%) $22.05
Platinum
(1.41%) 919.60
USD/EUR
(0.05%) 0.946
USD/NOK
(0.11%) 10.71
USD/GBP
(0.07%) 0.820
USD/RUB
(0.00%) 96.48
Picture of a house with link to the home page

Realtime updates for Cybin Inc. [CYBN]

Exchange: AMEX Sector: Healthcare Industry: Biotechnology
Last Updated29 Sep 2023 @ 16:00
Share On:
50% discount on Stockinvest.us - Use code: Podcast

8.80% $ 0.531

Live Chart Being Loaded With Signals

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Today's Volume 3.89M
Average Volume 4.29M
Market Cap 138.17M
Next earnings date 2023-11-13 ( $-0.0400)
P/E -3.32
ATR14 $0.0040 (0.76%)

Volume Correlation

Long: 0.35 (neutral)
Short: 0.75 (moderate)
Signal:(41.022) Neutral

Cybin Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Correlation - Currency/Commodity

The country flag 0.47
( neutral )
The country flag 0.70
( moderate )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.52
( weak )

Cybin Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.220
Q4 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0709
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0426
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.0291

Cybin Inc.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

Estimated
 CYBN Next Dividend
 (Unknown) $0 Probabilty 0 %
Quarter Ratio
 CYBN 0.00 0.00
Pay Frequency
 CYBN Insufficient data to determine frequency 0
Yearly Payout
 CYBN

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

DISCLAIMER:

"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 3.035355091095 seconds
Number of API calls: 1
Number of DB calls: 9